Our lab focuses on mechanisms that regulate gene expression with a special emphasis on how the DNA-packaging structure of chromatin is manipulated during genomic processes. Our findings inform the study of cancer and other diseases, and ultimately drug discovery.
NewsMarch 2019Congrats to our postdoc, Charly, on receiving an F32 grant from the NCI!Congrats to our graduate student, Sierra, on receiving an F31 NRSA Fellowship from the NCI!Congrats to our postdoc, Gabor Egervari, on two recent fellowships – Alzheimer’s Association Research Fellowship and the Brody Family Medical Trust Fellowship!February 2019Newest work out of our lab showing the role of p300 in senescence2019 Parker Scholar, Sierra McDonald, wants to improve CAR-T therapy. She’s one of PICI’s rising stars working to solve cancerPHL Business Journal profiled rising company, EpiVario, last week, originating from research in our lab hoping to treat post-traumatic stress disorder. Check it out!Congratulations to Shelley Berger for being appointed Co-Leader of the Tumor Biology Program at the Abramson Cancer Center! 👏🎉
Shelley L. Berger, PhD.
Shelley Berger, Ph.D., is the Daniel S. Och University Professor at University of Pennsylvania (Penn) and is a faculty member in the Cell & Developmental Biology Department and the Genetics Department in the Perelman School of Medicine, as well as the Biology Department in the School of Arts and Sciences. Dr. Berger also serves as Director of the Epigenetics Institute at Penn School of Medicine. Dr. Berger is an elected member of the National Academy of Science, the National Academy of Medicine, the American Academy of Arts and Sciences, and the American Association for Advancement of Science.Learn more about Shelley L. Berger, PhD. >